EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

RELEVANT LEGISLATION
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list

Stranica 37 od 99
50 Broj stavki po stranici
Prikaz 1.801 - 1.850 od 4.917 rezultata.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU REACH: List of SVHC
EU_BA Directive 2000/54/EC
 
iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate
616-510-7
7782-63-0
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Details
iron (II) sulfate
231-753-5
7720-78-7
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Details
IPSP; S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
-
5827-05-4
Acute Tox. 1; Acute Tox. 3
Details
iprovalicarb (ISO); isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate
604-209-3
140923-17-7
Carc. 2
Details
iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-9
36734-19-7
Carc. 2
Details
iprobenfos(ISO); S-benzyl diisopropyl phosphorothioate
247-449-0
26087-47-8
Acute Tox. 4
Details
ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
603-038-1
125225-28-7
Repr. 1B; Acute Tox. 4; STOT RE 2
Details
ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate
223-375-4
3861-47-0
Repr. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
Details
ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile
216-881-1
1689-83-4
Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
Details
iodoxybenzene
-
696-33-3
Expl.
Details
iodoacetic acid
200-590-1
64-69-7
Acute Tox. 3; Skin Corr. 1A
Details
iodine
231-442-4
7553-56-2
Acute Tox. 4
Details
Inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex
-
-
Acute Tox. 2; Acute Tox. 1; STOT RE 2
Details
indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate
605-683-4
173584-44-6
Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
Details
indium phosphide
244-959-5
22398-80-7
Carc. 1B; Repr. 2; STOT RE 1
Details
imiprothrin (ISO); reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate
428-790-6
72963-72-5
Carc. 2; Acute Tox. 4; STOT SE 2
Details
imidazole
206-019-2
288-32-4
Repr. 1B; Acute Tox. 4; Skin Corr. 1C
Details
imidazo[1,2-b]pyridazin hydrochloride
431-510-5
18087-70-2
Acute Tox. 4; Eye Irrit. 2
Details
imidacloprid (ISO); (E)-1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolidin-2-ylideneamine; (2E)-1-[(6-chloropyridin-3-yl) methyl]-N-nitroimidazolidin-2-imine
428-040-8
138261-41-3
Acute Tox. 3
Details
imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1- methylethyl)-5-oxo-1H- imidazol-2-yl]-3-pyridine carboxylate
617-219-8
81334-34-1
Eye Irrit. 2
Details
imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
601-305-7
114311-32-9
Repr. 2
Details
imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate;imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate
261-351-5
58594-72-2
Acute Tox. 4; Skin Sens. 1
Details
imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate;imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate
261-351-5
58594-72-2
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
Details
imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
252-615-0
35554-44-0
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1
Details
hyoscyamine
202-933-0
101-31-5
Acute Tox. 2
Details
hyoscine
200-090-3
51-34-3
Acute Tox. 2; Acute Tox. 1
Details
hymexazol (ISO);3-hydroxy-5-methylisoxazole
233-000-6
10004-44-1
Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
hydroxyphosphonoacetic acid
DP-3337
405-710-8
23783-26-8
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1
Details
hydroxylammonium nitrate
236-691-2
13465-08-2
Expl. 1.1; Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylammonium hydrogensulfate hydroxylamine sulfate(1:1)
233-154-4
10046-00-1
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylammonium chloride; hydroxylamine hydrochloride
226-798-2
5470-11-1
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylamine phosphate
244-077-0
20845-01-6
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylamine dihydrogenphosphate
242-818-2
19098-16-9
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylamine 4-methylbenzenesulfonate
258-872-5
53933-48-5
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
hydroxylamine ... % [> 55 % in aqueous solution];hydroxylamine ... % [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
hydroxylamine ... % [> 55 % in aqueous solution];hydroxylamine ... % [≤ 55 % in aqueous solution]
232-259-2
7803-49-8
Unst. Expl.; Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
hydroxyisohexyl 3-cyclohexene carboxaldehyde (INCI); reaction mass of 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde and 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde
641-410-5
130066-44-3
Skin Sens. 1A
Details
hydroxydisulfito platinum(II)acid
423-310-1
61420-92-6
Acute Tox. 4; STOT RE 2; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1
Details
hydroxo(2-(benzenesulfonamido)benzoato)zinc(II)
SICORIN E 10197
403-750-0
113036-91-2
Acute Tox. 4
Details
hydrogen sulphide
231-977-3
7783-06-4
Press. Gas; Acute Tox. 2
Details
hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate
2-BUTANEDIOIC ACID, MONOAMIDE WITH N-(9-OCTADECENYL)-3-AMINO
402-970-4
148292-42-6
Skin Sens. 1
Details
hydrogen peroxide solution... %
231-765-0
7722-84-1
Ox. Liq. 1; Acute Tox. 4; Skin Corr. 1A
Details
hydrogen cyanide ... %; hydrocyanic acid ... %;hydrogen cyanide; hydrocyanic acid
200-821-6
74-90-8
Acute Tox. 2; Acute Tox. 1
Details
hydrogen cyanide ... %; hydrocyanic acid ... %;hydrogen cyanide; hydrocyanic acid
200-821-6
74-90-8
Flam. Liq. 1; Acute Tox. 2
Details
hydrogen
215-605-7
1333-74-0
Flam. Gas 1; Press. Gas
Details
hydrofluoric acid ... %;hydrogen fluoride
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
hydrofluoric acid ... %;hydrogen fluoride
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
hydrochloric acid ... %;hydrogen chloride
231-595-7
7647-01-0
Press. Gas; Acute Tox. 3; Skin Corr. 1A
Details
hydrochloric acid ... %;hydrogen chloride
231-595-7
7647-01-0
Skin Corr. 1B; STOT SE 3
Details
Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined; Low boiling point modified naphtha [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 o C to 99 o C (201 °F to 210 °F).]
A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94°C to 99°C (201°F to 210°F).
295-436-3
92045-55-1
Carc. 1B; Muta. 1B; Asp. Tox. 1
Details
Stranica 37 od 99
50 Broj stavki po stranici
Prikaz 1.801 - 1.850 od 4.917 rezultata.

Export search results to: